vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Jianzhi Education Technology Group Co Ltd (JZ). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.1M, roughly 1.6× Jianzhi Education Technology Group Co Ltd). Jianzhi Education Technology Group Co Ltd runs the higher net margin — -111.1% vs -150.5%, a 39.4% gap on every dollar of revenue. INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-1.8M).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Jianzhi Education Technology Group Co Ltd is a China-based education technology provider focused on vocational training services. It offers professional qualification exam preparation courses, practical skill upgrading programs, and digital learning resources tailored for learners across industries including finance, information technology, and education, serving primarily the domestic Chinese market.

IVF vs JZ — Head-to-Head

Bigger by revenue
IVF
IVF
1.6× larger
IVF
$1.8M
$1.1M
JZ
Higher net margin
JZ
JZ
39.4% more per $
JZ
-111.1%
-150.5%
IVF
More free cash flow
IVF
IVF
$52.7K more FCF
IVF
$-1.8M
$-1.8M
JZ

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
IVF
IVF
JZ
JZ
Revenue
$1.8M
$1.1M
Net Profit
$-2.6M
$-1.2M
Gross Margin
19.8%
Operating Margin
-93.1%
-115.2%
Net Margin
-150.5%
-111.1%
Revenue YoY
22.6%
Net Profit YoY
-62.2%
EPS (diluted)
$-0.77
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
JZ
JZ
Q3 25
$1.8M
Q2 25
$1.9M
$1.1M
Q1 25
$1.6M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.8M
$4.0M
Q1 24
$1.6M
Q4 23
$1.4M
Net Profit
IVF
IVF
JZ
JZ
Q3 25
$-2.6M
Q2 25
$-5.3M
$-1.2M
Q1 25
$-17.4M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-2.2M
Q1 24
$-1.6M
Q4 23
$-2.0M
Gross Margin
IVF
IVF
JZ
JZ
Q3 25
Q2 25
19.8%
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
19.9%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
IVF
IVF
JZ
JZ
Q3 25
-93.1%
Q2 25
-160.4%
-115.2%
Q1 25
-1042.1%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-109.2%
Net Margin
IVF
IVF
JZ
JZ
Q3 25
-150.5%
Q2 25
-283.6%
-111.1%
Q1 25
-1060.1%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-122.2%
Q1 24
-101.3%
Q4 23
-144.4%
EPS (diluted)
IVF
IVF
JZ
JZ
Q3 25
$-0.77
Q2 25
$-13.30
$-0.01
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
JZ
JZ
Cash + ST InvestmentsLiquidity on hand
$985.5K
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$2.1M
Total Assets
$18.8M
$8.0M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
JZ
JZ
Q3 25
Q2 25
$985.5K
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Total Debt
IVF
IVF
JZ
JZ
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
IVF
IVF
JZ
JZ
Q3 25
$5.8M
Q2 25
$2.6M
$2.1M
Q1 25
$3.3M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$1.4M
$961.1K
Q1 24
$10.2K
Q4 23
$892.8K
Total Assets
IVF
IVF
JZ
JZ
Q3 25
$18.8M
Q2 25
$19.3M
$8.0M
Q1 25
$31.7M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
$2.8M
Q1 24
$17.3M
Q4 23
$18.5M
Debt / Equity
IVF
IVF
JZ
JZ
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
JZ
JZ
Operating Cash FlowLast quarter
$-1.8M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
$-1.8M
FCF MarginFCF / Revenue
-101.6%
-171.5%
Capex IntensityCapex / Revenue
0.5%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
JZ
JZ
Q3 25
$-1.8M
Q2 25
$-1.7M
$-1.8M
Q1 25
$-3.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-714.9K
Free Cash Flow
IVF
IVF
JZ
JZ
Q3 25
$-1.8M
Q2 25
$-1.7M
$-1.8M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
IVF
IVF
JZ
JZ
Q3 25
-101.6%
Q2 25
-92.6%
-171.5%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
IVF
IVF
JZ
JZ
Q3 25
0.5%
Q2 25
0.5%
0.1%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons